Measurement and reporting of burden of disease for hepatitis A: Results of the EUROHEP.NET feasibility survey

European Journal of Public Health

Volumn 17, Issue 1, 2007, Pages 69-74

  Bonanni, P ^a   Boccalini, S ^a   Bechini, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Burden of disease; Feasibility study; Hepatitis A; Networks; Surveillance

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ADULT; ARTICLE; DEATH; FEASIBILITY STUDY; HEPATITIS A; HEPATITIS B; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; COST OF ILLNESS; DATA COLLECTION; EUROPE; FEASIBILITY STUDIES; HEPATITIS A; HOSPITALIZATION; HUMANS; INTERNET; LENGTH OF STAY; LIVER TRANSPLANTATION; POPULATION SURVEILLANCE;

EID: 33846842391     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckl088     Document Type: Article

References (26)

1. Crowcroft NS, Walsh B, Davison KL, Gungabissoon U. On behalf of PHLS Advisory Committee on Vaccination and Immunization. Guidelines for the control of hepatitis A virus infection. Commun Dis Public Health 2001;4:213-27.
2. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004;132:1005-22.
3. Diel R, Schneider S. Transmission of hepatitis A in Hamburg, Germany, 1998-1999 - A prospective population based study. Eur J Epidemiol 2001;17:175-182.
4. Dentinger CM, Heinrich NL, Bell BP, Fox LAM, Katz DJ, Culver DH, Shapiro CH. A prevalence study of hepatitis A virus infection in a migrant community: is hepatitis A vaccine indicated? J Pediatr 2001;138:705-9.
5. Mele A, Stroffolini T, Palumbo F, et al. Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-years surveillance. J Hepatol 1997;26:743-7.
6. Van Gorkom J, Leentvaar-Kuijpers A, Kool JL, Coutinho RA. Annual epidemics of hepatitis A in four large cities related to holiday travel among immigrant children. Ned Tijdschr Geneeskd 1998;142:1919-23 (in Dutch).
7. Bonanni P, Colombai R, Franchi G, Lo Nostro A, Comodo N, Tiscione E. Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. Epidemiol Infect 1998;121:377-80.
8. Bonanni P, Normann A, Flehmig B, et al. A common source outbreak of hepatitis A in Italy: case-control study and molecular characterization of isolates. Abstract of the IX Triennial International Symposium on Viral Hepatitis and Liver Disease. April 21-25, 1996, Rome, Italy, p. 65, 1996 (abstract).
9. Bell A, Ncube F, Hansell A, et al. An outbreak of hepatitis A among young men associated with having sex in public venues. Commun Dis Public Health 2001;4:163-70.
10. Reintjes R, Bosman A, de Zwart O, Stevens M, van der Hoek K. Outbreak of hepatitis A in Rotterdam associated with visits to "darkrooms" in gay bars. Commun Dis Public Health 1999;2:43-6.
11. Mazick A, Howitz M, Rex S, et al. Hepatitis A outbreak among MSM linked to casual sex and gay saunas in Copenhagen, Denmark. Eurosurveillance 2005;10:111-4.
12. Mayans MV, Sanz B, Armengol P, Loureiro R. Outbreaks of infectious syphilis and other STIs in men who have sex with men in Barcelona, 2002-3. Eurosurveillance Weekly 2004; oct 28;10(44) 041028 available at: http://www.eurosurveillance.org/ew/2004/041028.asp#4.
13. Delarocque-Astagneau E. Epidemic of hepatitis A among homosexual men in Paris, 2000. Eurosurveillance Weekly 2001; Nov 15;11(46) 011115 (available at: http://www.eurosurveillance.org/ew/2001/011115.asp#4).
14. Stroffolini T, Pretolani S, Miglio F, et al. Population-based survey of hepatitis A infection in the Republic of San Marino. Eur J Epidemiol 1997;13:687-9.
15. Beran J, Douda P, Rychly R. Seroprevalence of viral hepatitis A in the Czech Republic. Eur J Epidemiol 1999;15:805-8.
16. Cianciara J. Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 2000;18 Suppl 1:S68-70.
17. EUROHEP.NET. Surveillance and Prevention of Vaccine Preventable Hepatitis. EUROHEP.NET;2004 (available at www.eurohep.net).
18. Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European centre for disease prevention and control.
19. WHO. Hepatitis A (available at: http://www.who.int/csr/disease/hepatitis/ en/HepatitisA_whocdscsredc2000_7.pdf).
20. Wu C, Chang HG, McNutt LA, Smith PF. Estimating the mortality rate of hepatitis C using multiple data sources. Epidemiol Infect 2005;133:121-5.
21. Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 2005;164:366-70.
22. Hoque ME, Hope VT, Scragg R, Graham J. Under-notification of giardiasis in Auckland, New Zealand: a capture-recapture estimation. Epidemiol Infect 2005;133:71-9.
23. Jansson A, Arneborn M, Ekdahl K. Sensitivity of the Swedish statutory surveillance system for communicable disease 1998-2002, assessed by the capture-recapture method. Epidemiol Infect 2005;133:401-7.
24. Breen E, Ghebrehewet S, Regan M, Thomson APJ. How complete and accurate is meningococcal disease notification? Commun Dis Public Health 2004;7:334-8.
25. WHO. International Classification of Diseases (ICD) (available at: http://www.who.int/classifications/icd/en).
26. WHO. International Classification of Diseases (ICD). ICD Implementations by countries (available at: http://www3.who.int/icd/1.htm).